← Back to Dashboard

Darunavir

HIV protease inhibitor

2D Structure

Could not render structureView on PubChem

3D Structure

No structure available on PubChemSearch PubChem

Chemical Identifiers

CC(C)CN(CC(C(CC1=CC=CC=C1)NC(=O)OC2COC3C2CCO3)O)S(=O)(=O)C4=CC=C(C=C4)…
CJBJHOAVZSMMDJ-HEXNFIEUSA-N
ClinicalTrials.govPubMed

Clinical Development by Virus3

FDA approved
Preclinical
Phase 2positive
Phase 3positive
Approved
FDAJapanRussia
Approval ref: AntiviralDbApproval ref (kegg.jp) Approval ref (pmda.go.jp)
Human immunodeficiency virus 1
HIV-1
Target: Viral protease
FDA approved
Preclinical
Phase 2positive
Phase 3positive
Approved
FDAJapanRussia
Approval ref (kegg.jp) Approval ref (pmda.go.jp) DB01264
Approved (other)
Preclinical
Phase 2
Phase 3
Approved
JapanRussia
Approval ref (kegg.jp) Approval ref (pmda.go.jp) PMID:33243253